CMV infection and allograft rejection.
Häyry
P
P
Transplantation Laboratory, University of Helsinki, Finland.
Lemström
K
K
von Willebrand
E
E
Tikkanen
J
J
Koskinen
P
P
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy; D015774:Ganciclovir / Q000627:therapeutic use*; D006084:Graft Rejection / Q000150:complications*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D011183:Postoperative Complications; D051381:Rats
D000998:Antiviral Agents; D002121:Calcium Channel Blockers; D015774:Ganciclovir